Cargando…
Association of beta-2-microglobulin and cardiovascular events and mortality: A systematic review and meta-analysis
BACKGROUND AND AIMS: Beta-2-microglobulin (B2M) has been suggested as an emerging biomarker for cardiovascular diseases (CVD), including coronary heart disease (CHD) and stroke, and mortality. METHODS: Three databases were searched from inception to January 2, 2020, supplemented by scanning referenc...
Autores principales: | Shi, Fanchao, Sun, Luanluan, Kaptoge, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955279/ https://www.ncbi.nlm.nih.gov/pubmed/33581388 http://dx.doi.org/10.1016/j.atherosclerosis.2021.01.018 |
Ejemplares similares
-
The prognostic values of beta-2 microglobulin for risks of cardiovascular events and mortality in the elderly patients with isolated systolic hypertension
por: Wang, Hai-Jun, et al.
Publicado: (2018) -
Association of beta-2-microglobulin with cardiovascular and all-cause mortality in the general and non-CKD population
por: Fang, Hang, et al.
Publicado: (2023) -
Increased urinary beta 2-microglobulin in cadmium exposure: dose-effect relationship and biological significance of beta 2-microglobulin.
por: Tsuchiya, K, et al.
Publicado: (1979) -
Expression of beta-2-microglobulin by nasopharyngeal carcinoma.
por: Shiu, W., et al.
Publicado: (1992) -
Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis
por: Haycock, Philip C, et al.
Publicado: (2014)